Specialist Updates 
Rheumatology

Study backs anti-TNFs for rheumatology patients with COVID-19

Monotherapy gave the best outcomes in an analysis of data from three registries
Reuters Health
0
4 November 2021
Save
ClosePlease login
Coronavirus particles

Pooled data from three international COVID-19 registries support the use of TNF inhibitor monotherapy in patients with rheumatoid arthritis and other immune-mediated inflammatory diseases.

But, compared to TNF inhibitor monotherapy, some other therapies — including methotrexate monotherapy, Janus kinase (JAK) inhibitors or azathioprine/6-mercaptopurine — worsen the odds of severe COVID-19 in such patients, the investigators report.  

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .